Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nalbuphine hydrochloride [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de nalbuphine 10 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de nalbuphine 10 mg/mL, ampoule de 2 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
Nalbuphine hydrochloride [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
Nalbuphine hydrochloride 20mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
Product containing nalbuphine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely nalbuphine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely nalbuphine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nalbuphine hydrochloride |
Inferred relationship |
Some |
1 |